Sampling point (Source: by Yonggang Huang (223155)

Subjects:

Box plots representing comparisons of PVS volumes across different variables with statistical comparison annotations for TP(a), DOSE(b), Shunt(c), Anesthesia(d), and Sex(e). by Ruitian Song (11045127)

Subjects:

PVS ratio comparisons across different variables using box plots with statistical comparison annotations for TP(a), DOSE(b), Shunt(c), Anesthesia(d), and Sex(e). by Ruitian Song (11045127)

Subjects:

Variations in slope utilization by a female red panda across different time periods and in comparison with their wild individuals. Different capital letters indicated significant d... by Yanshan Zhou (14131359)

Subjects:

Variations in altitude utilization by a female red panda across different time periods and in comparison with wild individuals. Different capital letters indicated significant diff... by Yanshan Zhou (14131359)

Subjects:

Variations in aspect utilization by a female red panda across different time periods and in comparison with wild individuals. Different capital letters indicated significant differ... by Yanshan Zhou (14131359)

Subjects:

Average stability values (mean ± standard deviation) and statistical results. by Hyung Suk Yang (20442438)

Subjects:

The influence of <i>PINK1</i> on <i>P</i>. <i>berghei</i> infection in <i>A</i>. <i>stephensi</i>. by Li Gao (131516)

Subjects:

The body weight and cholesterol levels of the mice were recorded before the administration of the drug. by Xueqin lu (22250795)

Subjects:

Effects of Kylo-0603 on body weight, organ weight, and body fat content. by Xueqin lu (22250795)

Subjects:

Photosynthetic efficiency (<i>Fv/Fm</i>) of (A) <i>Acropora</i> sp. and (B) <i>P. verrucosa</i> for the four groups. by Malte Ostendarp (13217973)

Subjects:

Mean total cholesterol levels over time in the roxadustat group (A) and ESAs group (B) according to the statins subgroup. by Jie Liu (15128)

Subjects:

Participants enrollment. by Chikondi Maluwa (20660522)

Subjects:

KAP assessment scores (n = 422). by Chikondi Maluwa (20660522)

Subjects:

After 8 weeks of treatment, body fat analysis and bone mineral density testing of mice in each group. by Xueqin lu (22250795)

Subjects:

Pharmacological efficacy of Kylo-0603 in MASH mouse models (F2 ~ 3). by Xueqin lu (22250795)

Subjects:

Plasma cholesterol and LDL-C levels. by Xueqin lu (22250795)

Subjects:

The Chol and TG content in liver homogenates of the mice in each group after 2 and 10 weeks of drug intervention. by Xueqin lu (22250795)

Subjects:

Hematoxylin and eosin (H&E) staining, Sirius Red staining, and Oil Red staining of liver tissues from mice in each group after 8 weeks of treatment with either vehicle or Kylo-0603... by Xueqin lu (22250795)

Subjects:

IC₅₀ values (mean ±SD in μM) of <i><i>in vitro</i></i> DPPH-radical scavenging properties vs. ascorbic acid and antiinflammation propensities vs. indomethacin of the tes... by MohammedBashar Al-Qazzan (22439236)

Subjects: